800
Participants
Start Date
December 15, 2023
Primary Completion Date
February 15, 2025
Study Completion Date
March 15, 2025
biological and targeted synthetic disease modifying anti rheumatic drugs (bDMARDs) and (tsDMARDs)
This is a registry-based study. It is an observational, retrospective trial. There is/are no interventional drug(s).
RECRUITING
International medical center, Jeddah
Umm Al-Qura University
OTHER